L
The new drugs in Europe have seen a 40% decrease in their launch due to a presidential decree from Trump that aligned prices with those lower in some European countries, raising concerns about supply and markets. #Farmaci #SalutePubblica #MercatoFarmaceutico (translated)
I nuovi farmaci giù del 40%: “In questo modo Trump ha stravolto il mercato Ue”
